Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 4, 2008, Pages 1016-1019

  Brooks, Jennifer ^a   Shore, Roy E ^a   Zeleniuch Jacquotte, Anne ^a   Currie, Diane ^a   Afanasyeva, Yelena ^a   Koenig, Karen L ^a   Arslan, Alan A ^a   Toniolo, Paolo ^a   Wirgin, Isaac ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; RAD51 PROTEIN; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; COHORT STUDIES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; MIDDLE AGED; NEW YORK; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RAD51 RECOMBINASE; WOMEN'S HEALTH;

EID: 42149177762     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0065     Document Type: Article

References (35)

1. Begg CB, Haile RW, Borg A, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008;299:194-201.
2. Antoniou A, Pharoah P, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
3. Zeleniuch-Jacquotte A, Shore R, Koenig K, et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 2004;90:153-9.
4. Shore R, Zeleniuch-Jacquotte A, Currie D, et al. Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int J Cancer 2008;122:2101-5.
5. Kadouri L, Kote-Jarai Z, Hubert A, et al. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer 2004;90:2002-5.
6. Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11:1399-407.
7. Rafii S, O'Regan P, Xinarianos G, et al. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum Mol Genet 2002;11:1433-8.
8. García-Closas M, Egan KM, Newcomb PA, et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 2006;V119:376-88.
9. Packer B, Yeager M, Burdett L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006;34:D617-21.
10. Manuguerra M, Saletta F, Karagas MR, et al. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol 2006;164:297-302.
11. Smith TR, Miller MS, Lohman K, et al. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 2003b;190:183-90.
12. Jacobsen NR, Nexo BA, Olsen A, et al. No Association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:584-5.
13. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
14. Han S, Zhang H-T, Wang Z, et al. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur J Hum Genet 2006;14:1136-44.
15. Ries L, Melbert D, Krapcho M, et al., editors. SEER cancer statistics review, 1975-2004. Bethesda, MD: National Cancer Institute; 2006.
16. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005;219:125-35.
17. Costa S, Pinto D, Pereira D, et al. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 2007;103:209-17.
18. Jara L, Acevedo ML, Blanco R, et al. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population. Cancer Genet Cytogenet 2007;178:65-9.
19. Levy-Lahad E, Lahad A, Eisenberg S, et al. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci U S A 2001;98:3232-6.
20. Wang WW, Spurdle AB, Kolachana P, et al. A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2001;10:955-60.
21. Antoniou A, Sinilnikova O, Simard J, et al. RAD51 135G→C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007;81:1186-200.
22. Lee K-M, Choi J-Y, Kang C, et al. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 2005;11:4620-6.
23. Webb PM, Hopper JL, Newman B, et al. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005;14:319-23.
24. Jakubowska A, Gronwald J, Menkiszak J, et al. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 2007;16:270-5.
25. Han J, Hankinson SE, Ranu H, et al. Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. Carcinogenesis 2004;25:189-95.
26. Han J, Hankinson SE, Zhang SM, et al. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:520-4.
27. Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001;22:1437-45.
28. Au W, Salama S, Sierra-Torres C. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 2003;111:1843-50.
29. Fuller L, Painter R. A Chinese hamster ovary cell line hypersensitive to ionizing radiation and deficient in repair replication. Mutat Res 1988;193:109-21.
30. Caldecott K, Jeggo P. Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents. Mutat Res 1991;255:111-21.
31. Sangrajrang S, Schmezer P, Burkholder I, et al. The XRCC3 Thr241Met polymorphism and breast cancer risk: a case control study in a Thai population. Biomarkers 2007;12:523-32.
32. Smith TR, Levine EA, Perrier ND, et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003a;12:1200-4.
33. Thyagarajan B, Anderson KE, Folsom AR, et al. No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study. Cancer Detect Prev 2006;30:313-21.
34. The Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2006;98:1382-96.
35. Reliene R, Bishop AJR, Schiestl RH, et al. Involvement of homologous recombination in carcinogenesis. Adv Genet 2007;58:67-87.